Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice little promo, hope it increases sales! I guess we will see. Don't know how much it will do for the stock though :/
Time for investors to pick up what the dumpy traders left us :)
1.8 Buy/Sell today!
When they create the Class with $1 shares that could be a real possibility. Will have to be able to maintain the value of those shares though.
anddd BOUNCE...BOUNCE...BOUNCE
GO $CBIS
Almost 400% from mid July, can't just teleport to the moon :) But anyways, the balance sheet is kind of a mess liabilities/assets is enormous, and we operated at a loss of $500,000 last qurater. So any true valuation of this company is coming from past sales and expected sales. And for that so far we have:
Fuel Emulsions International Inc.: 2 NPU-60 Diesel Emulsion units at a unit price of $550,000 each for a total of $1,100,000 and 2 NPU-60 (#6) Emulsion units at a unit price of $600,000 per until for a total of $1,200,000. Eight (8) containers of our proprietary additive $60,000 a piece. Total = $2,408,000. 0Each of these NPUs consumes $4500 a day of additive when in full production. At half capacity, or 12 hours/day EcoloCap can expect a minimum of 24 containers of additive per year in additional sales for this order.
Nice, sales of $2,408,000 but that's not nearly enough to send us to the moon. Market Value: $5,344,934 is already considering our debt. This thing is even as high as it is because of future expectations of sales. I personally believe we are going to start getting some amazing deals done, but until then I don't think we can be much higher. Next big order = next big boom :) IMHO
Bounce...Bounce....Bounce
Real Deal Here
GLTA!
$CBIS
Into the .03's today...
And it shall be remembered:)
Hoping for a nice day here. GO ECOS!
Dilution over?
I wonder if Dollar-Volume-Weighted-Average-Price would work? Haven't really thought about it but it seems like it might be more accurate?
What do the Entities of Cannabis Science Do?
Rockbrook, Inc
- September 30, 2012, the Company is re-assessing the license agreement with Rockbrook and how to resolve the dispute to move forward in a cohesive arrangement with the other license agreements and acquisitions the Company is working on.
Apothecary Genetics Investments LLC
-February 9, 2012, the Company signed a license agreement with Apothecary Genetics Investments LLC. to produce several Cannabis Science Brand Formulations for the California medical cannabis market. As well, Apothecary will provide research and development facilities with full circle operations including a California laboratory facility for internal research and development, along with 16 unique genetic strains specifically generated and maintained by a cancer survivor who recognizes the importance of proper growth and breeding. The Company earned a $25,000 license fee under the agreement for the period ended September 30, 2012.
GGECO University, Inc.
-February 9, 2012, the Company acquired GGECO University, Inc. (“GGECO”), an online video-based medical cannabis education system, offering courses dealing with medical cannabis law, the benefits of medical marijuana, cooking, horticulture, and bud tending. Following the university's name change to Cannabis Science University, the Company hopes to use this platform to educate the general public, patients, and even those who have already been involved in the medical cannabis industry on the medical benefits of cannabis, how it is grown, how to use it safely, and the many applications or ways to administer the medication
Cannabis Consulting Inc.
On March 21, 2012, the Company acquired Cannabis Consulting Inc. (“CCI Group”), which consists of a group of businesses operated by Robert J. Kane, including: all contracted rights, properties, patents, trademarks, and distribution rights and agreements pertaining to Cannabis Consulting Inc., Robert Kane Partners, Kaneabis Consulting, Kaneabis Fund, Kaneabis Report, and Kaneabis Radio.
Dupetit Natural Products GmbH
On July 27, 2012, the Company entered into a Joint Venture Operating Agreement (“JV”) with Dupetit Natural Products GmbH (“DNPG”). Under the Agreement the Company is entitled to 90% of net operating profits of the JV. The Company issued 5,000,000 common shares with a fair market value of $260,000 to the principal of DNPG as consideration for the provision of dozens of hemp and cannabis based products.DNPG currently distributes and sells (ABOUT 12) products throughout Europe
1Hemp Extracts:
(i)Pure CO2-Extract of European fiber hemp, CBD and other interesting compounds.CO2 organic hemp total extract (320 bar pressure) is actually available. This extract has shown to be very effective against Herpes (Labialis) and for sure has many other possibilities to be investigated as a business opportunity now.
(ii)Organic German fiber EU-hemp (low THC-content and high CBD content) dried tops available. Used to extract for flavors, perfume and cosmetic creams.
(iii)Agreements in Switzerland and France for the purchase of essential hemp oil to secure availability.
2.Essential oils, cannabis perfume, a mix of oils without using cannabis itself.
3.100% natural scented “Cannabis” and “Canna” cosmetics.
4.TMs “Cannabis” and “Canna” cosmetics and perfume.
5.Produces Food, cosmetics, beverages (“Canna Cola”), rough building materials (hemp shelves), textiles, clothing, etc.
6“BioCanna” and “Canna” Biss
7.Organic cold pressed hemp oil (“BioCanna”)
8.“Canna” biscuits
9.“Cannabia” (Hemp Beer)[color=green][/color]
(i)Today this hemp beer is since the beginning produced in Germany. Cannabía® first hemp beverage (Cannabis beer) of mankind was born in March 1996, when Germany officially authorized the cultivation of hemp, the so called “fiber hemp”. A secret combination of both by hand selected and harvested organic plants: hops and cannabis, give as result the unmistakable hemp aroma of Cannabía®. TM Cannabia can also be used for alcohol free beverages keeping its worldwide first status.
Cannabia TM is registered in the whole EU, Japan, China, Uruguay and USA.
(ii)Dupetit Natural Products was already working with and on hemp aroma for its food, sweets and perfume as well as the organic cosmetic line. Contacted an organic brewer to brew a "hemp beer" in a traditionally brewing way, an organic and pure hemp beer with Bavarian spring water and organic hemp.
(iii)Cannabia® then sought out one of the country's great master-brewers, who also had an understanding and respect for the concept of traditional, organic brewing, as well as the technical expertise to deliver a high-quality organic product for a good price. Together with Dupetit Natural Products he carefully crafted the idea into the finished recipe by adding to our organic German hemp this experience and knowledge, as well his organic malt, hops and yeast giving Cannabía® its unique taste.
(iv)Cannabía® is brewed in Germany. Cannabía® 1st legal hemp drink of mankind! The production of Cannabía® was authorized first 1996 in Germany by the Berliner health authorities.
(v)In the Meantime 2011 Cannabia® has explicit written permits in Greece, Cyprus, Germany, Poland, Bulgaria, Denmark, UK and circulate in more EU countries without the need of a permit, and in some countries outside of EU like Japan, Switzerland, and North Korea. Australia allows now hemp in food. This country will follow soon. Cannabia® TM is registered not only in the whole EU but also in many other countries as USA, China, Korea, Japan, Uruguay, Colombia and more.
(vi) Global sales of Cannabia® are of about 750.000 bottles /year only and growing due to new starting professional distribution channels as: Greece, Poland, Hong Kong and North Korea, alone in 2011. The value of Cannabia-Distribution only in Spain by a years quantity of 500.000 bottles sold there is of € 500.000.- due to the € 50.000.- that this distribution lets (free of tax and other costs) per year (at 0.10/bottle)
10. The development of Cannabia® was followed by another one, the development of the scent and scented products under the TM Cannabis®. They created several flavors for sweets, for Scratch & Smell Offset Lack, for wine, honey wine, for beer, cola, lemonades, energy drinks, shisha tobacco and more.
11. More Canna® sweets as chewing gum, jellies, chocolates and chocolate mints will be developed.
12.Online Shop Products (to be seen a):
(i)BioCanna® Organic Hemp nuts: All essential amino- acids contained! Organic Cannabis seeds No nuts allergens!
(ii)BioCanna® Organic shelled cannabis seeds: Rich in Omega-3-fatty acids (over 80%). No nuts allergens.
(iii)BioCanna® Organic Hemp flour: Rich in Omega-3-fatty acids / hemp protein content: approx. 20% No nut allergens!
(iv)BioCanna® Organic Hemp flour / Biologisches Hanfmehl: Rich in Omega-3-fatty acids (over 80%). Over 20% organic vegetable hemp protein. No nut allergens!
(v)Cannabis® by dupetit ® The original since 1989, Organic Eau de Toilette, 100% natural product of the Year Cannabusiness 2004
INCI: Perfume (100% natural),* alcohol, *benzyl alcohol, *citral, *geraniol, * eugenol, *isoeugenol, *cinnamyl alcohol, * linalool, *limonene. *: Of natural origine contained in essential oils of this perfume// *Natürlich beinhaltet.
(vi)Cannabis® by dupetit ® Parfum, Roll On flakon 100% natural in hemp oil.
INCI: Perfume (100% natural),* Cannabis Sativa (hemp seeds oil), *benzyl alcohol, *citral, *geraniol, * eugenol, *isoeugenol, *cinnamyl alcohol, * linalool, *limonene. * natural origine contained in essential oils of this perfume// *Natürlich beinhaltet
(vii)Cannabis® the original, Organic Eau de Toilette , 100% natural Product of the Year Cannabusiness 2004.
INCI: Perfume (100% natural),* alcohol, *benzyl alcohol, *citral, *geraniol, * eugenol, *isoeugenol, *cinnamyl alcohol, * linalool, *limonene.*: natural origine contained in essential oils of this perfume// *Natürlich beinhaltet
(viii) Cannabis® Care cream by dupetit ® 50 ml scented with / parfümiert mit Cannabis® by dupetit® 100% natural Crema con cáñamo 100% natural hemp body care / Hanf Körperpflege / Cannabis care cream / Hanfcreme / Cannabis body care
INCI: Cannabis Sativa (hemp seeds oil), bees wax, aloe barbadensis, alpha toccopherol (Natural E-Vitamin), Perfume (100% natural), *benzyl alcohol, *citral, *geraniol, * eugenol, *isoeugenol, *cinnamyl alcohol, * linalool, *limonene.*: natural origin contained in essential oils of this perfume//
(ix)Cannabis® Care cream by dupetit ® 50 ml 100 % natural non-scented
INCI: Cannabis Sativa (hemp seeds oil), bees wax, aloe barbadensis, alpha toccopherol (Natural E-Vitamin)
(x)Cannabis® Lip balm 5 ml Canna® lips 100% Natural and vegan. Fantastic against dried lips (specially during winter time!) and skin as well as mini cream tray for the pocket. Identical content as Cannabis® Care cream but stronger in its consistence. With Cannabis® flavor or without any scent (natural)
(xi)Canna®-Dermis by dupetit® Massage- & Body oil 100% natural. Very good for extreme dry skin, after pregnancy, or after a strong sunbath and for baby skin. Canna®Body Oil has the highest amount of cold pressed organic hemp nut oil than all other cosmetic items in this fantastic shop.
(xii)Cannabis scented postcards! Scratch & Smell effect! Hempy, sweet scent. 11 x 15 cm
(xiii)BioCanna® 30 Organic water-soluble cannabis aroma. 100% natural. THC-Free. 10 ml. Good for approx. 100 to 200 liter Wine, or 200 liter beer, 100 kg ice cream, etc. Not for hard sugar sweets or hot produced food. For oil-soluble BioCanna® 30 flavour: Please contact us directly.
(xiv)Cannabia® First legal hemp beverage (hemp beer) of mankind! THC free 5% Alc. vol. 0.33 l
(xv)Cannabia® First legal hemp drink (Hemp beer) worldwide! THC free 5% Alc. Vol 12 x 0,33l
(xvi) The 4 Elements® Organic German Premium Pilsner the new less bitter pilsner brewed with source water from the Röhn Region, Germany. www.the4elements.info the 5th Elements is you! Alc.: 5% 0,33 l:
(xvii)Canna® Power-Flower Pops, 100% natural pops with organic hemp flavor and paper sticks. Our hemp sweets are the only ones in the market with No synthetic colorants. All botanical extracts give the colors and 100% natural aroma!
(xviii)Canna® Power- Flower Pops (Taste: fresh flower) 100% natural pops with organic hemp flavor and paper sticks. No synthetic colorants. All botanical extracts give the colors and 100% natural aroma! THC free
(xix)Canna® Raggae-Pops 100% natural hand made pops with organic hemp flavor and paper sticks. No synthetic colorants. All botanical extracts gives the colors and 100% natural aroma! All botanical extracts give the colors and aroma! THC free hemp pops.
(xx) Canna® Raggae- Candies THC free 100% natural hemp candies with organic 100% natural hemp flavor. No synthetic colorants. All botanical extracts give the colors and 100% natural aroma!
(xxi)Organic Canna® Biscuits, vegan hemp food, with organic hemp seeds, org.chocolate, org. Bourbon vanilla and more! THC free 1 x 150 gr.
(xxii) BioCanna® Cold pressed & organic Hemp nuts oil / Rich in Omega-3-fatty acids (over 80%)
(xxiii)BioCanna® Cold pressed & organic Hemp oil
13.Canna® food, cosmetics, beverages (Europe) and more classes
14.TM Cannabia® for beer and alcohol free beverages and sirups in whole Europe and in Japan, USA, China, Uruguay, and soon more countries
15.Websites:
a)www.tecnobrau.com
b)www.ikon-europubs.com
c)http://www.facebook.com/#!/pages/Cannabis-Perfume/176142819063801
d)http://www.cannabia.co.kr/
e)http://www.facebook.com/profile.php?id=100002497295922
f)http://www.nature.com/bjc/journal/v95/n2/full/6603236a.html
g)www.dupetit.de
h)http://www.wipo.int/romarin
i)www.dronabinol.eu (maybe soon no more available if means needed for analytics)
j)www.dronabinol.de (no more available now)
k)www.cannabis.tel
l)www.cannacola.com
m)www.bioscent.info (maybe no more available soon)
n)www.dupetit.com
TMs
o)http://oami.europa.eu/CTMOnline/RequestManager/de_SearchBasic (Holder Name: dupetit)
p)Cannabis (Word TM): http://register.dpma.de/DPMAregister/marke/registerIR?AKZ=465209&CURSOR=0
q)Cannabia (Word & Image TM): http://register.dpma.de/DPMAregister/marke/registerHABM?AKZ=001967017&CURSOR=33
r Cannabia (Word-TM): http://register.dpma.de/DPMAregister/marke/register/396350976/DE
s)Cannabia Club (Word-TM): http://register.dpma.de/DPMAregister/marke/register/305582291/DE Also registered in Spain
t)dupetit (Word TM) http://register.dpma.de/DPMAregister/marke/register/2098448/DE
u) Cannabis Leaf shape bottle 3 dimensional TM (no more available) http://register.dpma.de/DPMAregister/marke/register/301388857/DE This may have being erased or will be erased very soon if not prolonged.
v) The 4 Elements (Word & Image TM) http://register.dpma.de/DPMAregister/marke/register/301054258/DE
w)BioCanna Word TM http://register.dpma.de/DPMAregister/marke/register/395228484/DE
x)Canna B Word TM) http://register.dpma.de/DPMAregister/marke/register/306008564/DE
y)Image TM (Lollipop image hand made rocks with a cannabis leaf in the middle) http://register.dpma.de/DPMAregister/marke/register/307640493/DE
z)The 4 Elements (Word & Image TM) http://register.dpma.de/DPMAregister/marke/register/3020110399875/DE
16.Actual Products Circulating in Europe:
i.Cannabia: Hemp beer since 1996 (distributed in over 16 countries worldwide, the most in the EU)
ii.Canna® Sweets (different hard sugar candies with hemp) since 2001
iii.Cannabis® Care Cream Since 1994
iv.Cannabis ® Perfume since 1994
v.Canna® Dermis, BioCanna®, Canna®: 100% natural and organic Cosmetic with hemp oil and extract
vi.BioCanna®: Organic cold pressed hemp nuts oil
vii.BioCanna®: Organic hemp nuts and shelled nuts as well as flour
viii.The 4 Elements® Organic German premium beer (only in: Spain, Greece, Japan, Germany (very little)
17.Projects:
i.Canna® Dent Tooth paste.
ii.BioCanna® Hemp caps containing hemp oil and hemp extract (with different spectrum of cannabinoids)
iii. BioCanna® or Canna® Dermis CO2-Hemp extract in or without oil as diluter
iv.Cannabis® Perfume in large industrial and commercial scale (see 3 dimensional bottle TM)
v.Cannabis® Cream with stronger CO2-Extract dose and more medicinal salves and pomades as well as creams, etc (with different spectrum of cannabinoids)
vi.Hemp Extraction mean (invention to extract finest fractions of fiber hemp)
vii.Medicinal vaporizers
18.Medicinal Cannabis seeds:
Seeds breeding in a legal/allowed place in Switzerland (or other places/Institutes in Europe and South America (possibly Uruguay) using GCMS and HPLC to secure process and control of different cultivars and strains from all over the world.
SHIMADZU has offered a GCMS-OP-2010S that fulfills all requirements for the breeding control.
Analytics will done at the breeding station and interpretation over internet by specialists there in the USA or in Germany where we have already discussed prices and conditions with THC-Pharm, The Health Concept Frankfurt or over Prof. Brenneisen, Bern (now retired) and his possibilities in Switzerland at the Dept. of Phytoresearch, University of Bern, Switzerland.
19.Canna®Med-Caps:
Production of organic encapsulated hemp oil with or without organic CO2-Extract in gelatin big caps of 500 mg to 1000 mg.”
Wolastokwik NeGoot-Gook, Maliseet Nation at Tobique (“WNGM”) and George Kattar.
On September 10, 2012, the Company entered into a Joint Venture Operating Agreement (“JV”) with Wolastokwik NeGoot-Gook, Maliseet Nation at Tobique (“WNGM”) and George Kattar. Under the JV, the Company is entitled to 25% of net operating profits from the JV, which will be focused on establishing a clinical laboratory, medicine production facility and treatment center on WNGM provided land and facilities at the Maliseet Nation.
Sorry formatting got iffy, it was taking forever and I suck!!!
Some Dupetit Natural Products GmbH Pictures from one the sites!
GO$CBIS
Hemp Beer: Would You Drink It?
http://simpleandgreen.net/2008/03/14/hemp-beer-would-you-drink-it/
Has anyone been tracking the A/S, O/S changes around here?
Excellent news!!
Could anyone TLDR me on why this company got so crushed? Would be much appreciated
Have some serious horizontal building going on for, man I cant even remember how long. Going to be quite a platform from which to build an epic pyramid :) GLTY GO CBIS!
Going to look back...the penny that went to a million, all while benefiting the human race!
Almost wanted to throw a penny in here and make a wish :)
What are you thinking sir? Rebound here or maybe .05?
More Doctors than I can even count ;) and all working on the different aspects weed has to offer! We may have ourselves here the greatest thing since penicillin. Got Lawyers and Marketers in there too! Even an ex member of the FDA. Should all align eventually :)
Executive Management
PS I think they are such a distinguished group of guys that I'm sure a lot of posters couldnt even dent their credentials
Corporate - Board of Directors
Dr. Robert J. Melamede, Ph.D. President & CEO
Dr. Melamede has a Ph.D. in Molecular Biology and Biochemistry from the City University of New York. He retired as Chairman of the Biology Department at University of Colorado, Colorado Springs in 2005, where he continues to teach. Dr. Melamede is recognized as a leading authority on the therapeutic uses of cannabinoids, and has authored or co-authored dozens of papers on a wide variety of scientific subjects. Dr. Melamede also serves on the Advisory Board of The Journal of the International Association for Cannabis as Medicine, and the Scientific Advisory Board Medical of the Marijuana Policy Advocacy Project, as well as the Scientific Advisory Board of Americans for Safe Access. He also served as a director of Newellink Inc, a Colorado-based company specializing in cancer research.
Richard Cowan Director, Chief Financial Officer
Mr. Cowan has a BA from Yale University in Economics and extensive experience in corporate finance. He was President of the Yale Young Republicans; Chairman of the Party of the Right in the Yale Political Union; Founding member of Young Americans for Freedom; etc. Mr. Cowan served on the boards of several publicly owned companies, and has extensive experience in corporate finance. Mr. Cowan was also a former CEO of NORML. During that time Mr. Cowan’s television appearances included interviews on numerous news programs, including CNN, and a variety of talk shows including Posner/Donahue.
Corporate - Executive Management
Dr. Moe Afaneh, Pharm. D. Chief Operating Officer
Dr. Afaneh holds a Doctor of Pharmacy degree from Nova Southeastern University College of Pharmacy; completed his doctorate in 6 years graduating at the top of his class, after which he received his MBA at Nova Southeastern University. Driven by a thirst for knowledge & determination to become a leader in the industry, to forge his mark in the medical community; he sought out to constantly gain more certifications & accreditation's; he became certified as an orthotic fitter, certified in providing vaccines, including Fluzone (the intra-nasal influenza vaccine), NIPCO certified in Osteoporosis, NIPCO certified in Long-Term Care & Hospice, NIPCO certified is Dyslipidemia and NPEC certified in chronic pain.
Ronald Sekura, Ph.D. - Executive Vice President of Regulatory Affairs
Dr. Sekura held the position of Food and Drug Administration (FDA) Research Chemist, Center for Biologics Evaluation and Review as well as Chief of the Pharmaceutical and Regulatory Affairs Branch of the Division of AIDS at The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institute of Health (NIH). Dr. Sekura’s career in drug development regulatory affairs spans over two decades with extensive experience in governmental regulatory requirements as well as publicly traded biotechnology. Dr. Ronald Sekura is currently President of VivoNex LLC and Biotechnology Assessment Services, Inc.
Dr. Sekura held the position of Research Chemist at The National Institute of Child Health and Human Development (NICHD) at the NIH and the Center for Biologics Evaluation and Research (CBER). He received his Bachelor of Science and Master of Science in Biochemistry degrees at Pennsylvania State University and his Ph.D., at Cornell University. Dr. Sekura is the author of over sixty scientific publications.
Andrew Pitsicalis International Brand & Licensing Director
Mr. Pitsicalis has been CEO of Rockin Artwork since 2010. Rockin Artwork is an intellectual property company. Having experience licensing properties that span a fan base of 2 billion people worldwide, he has licensed products in mass market retail stores around the globe. You can find Pitsicalis’ companies, licensed products in places like, Walmart, Target, Kohls, JC Penny, Urban Outfitters, Old Navy and other mass retail chains.
Mr. Pitsicalis’s role at Cannabis Science is to help build the brands of Cannabis Science. This will include consulting and brand management of Cannabis Science product lines, manufacture and develop the licensing platform for Cannabis Science, Patents and Trademarks. Mr. Pitsicalis will facilitate the advertising and licensing of products and branding of Cannabis Science. Pitsicalis will be selecting advertising campaigns for brand and product recognition. There are plans in the future to eventually license our biotechnology to pharmaceutical companies and other hemp related manufacturing licenses. Andrew has extensive connections to doctors, intellectual property, and venues for future medical cannabis conferences, all of which are invaluable to Cannabis Science.
Robert Kane Vice President of Investor Relations
Cannabis Science embraces Mr. Kane and his Kaneabis Brand. Each one of Mr. Kane's endeavors falls directly in line with Cannabis Science’s mission to be established as a viable pharmaceutical/nutraceutical business model and investment alternative for all investors. For over a decade Robert J. Kane worked for Stifel Nicolaus (NYSE: SF - News) as a registered representative. Today, Mr. Kane, along with Cannabis Science, will educate conservative Wall Street that Cannabis Science is a viable alternative investment opportunity that will also help improve the health of mankind.
Scientific Advisory Board
Corporate - Scientific Advisory Board
Roscoe M. Moore, Jr., D.V.M., Ph.D., D.Sc.
Until his retirement, Dr. Roscoe M. Moore, Jr. served with the United States Department of Health and Human Services (HHS) and was for the last twelve years of his career the principal person responsible for global development support within the Office of the Secretary, HHS, with primary emphasis on Continental Africa and other less developed countries of the world (e.g., Indonesia, Malaysia, and Vietnam). He was the principal liaison person between the HHS and Ministries of Health in Africa with regard to the development of infrastructure and technical support for the delivery of preventive and curative health needs for the continent. Dr. Moore represented the HHS in cooperative international efforts with African nations in addressing continued health and human resources issues.
Dr. Moore received his Bachelor of Science and Doctor of Veterinary Medicine degrees from Tuskegee Institute; his Master of Public Health degree in Epidemiology from the University of Michigan; and his Doctor of Philosophy degree in Epidemiology from the Johns Hopkins University. He was awarded the Doctor of Science degree (Honoris Causa) in recognition of his distinguished public health career by Tuskegee University.
Read More
Dr. Dorothy Bray, Ph.D.
Dorothy Bray, Ph.D., Former Global Director of HIV Research and Senior Clinical Program Head of HIV and Opportunistic Infections for GlaxoSmithKline, to the Company’s Scientific Advisory Board. Dr. Bray held various positions of responsibility at GlaxoSmithKline.
Dr. Bray is the President and owner of ImmunoClin as well as a member of the Scientific Staff and the Head of Scientific Business Development of The Medical Research Council Clinical Trials Unit. As well, Dr. Bray has authored or co-authored multiple publications and has an extensive network of collaborations and contacts with pharmaceutical companies, governments, and non- government organizations in key developed and developing markets; European Commission Scientific Expert.
Dr. Bray’s extensive experience in the field of HIV drug development will compliment Cannabis Sciences’ prestigious Scientific Advisory Board as the company embarks on the research and development of a phytocannabinoid based HIV TAT inhibitor. Dr. Bray has significant expertise in clinical development and market positioning for novel drugs.
Dr. Alan Shackelford
Dr. Alan Shackelford is a graduate of the University of Heidelberg School of Medicine in Heidelberg, Germany and completed his postgraduate medical training at major teaching hospitals of the Harvard Medical School, including a residency in internal medicine and clinical Fellowships in nutritional and behavioral medicine as well as a Harvard Medical School research fellowship.
Dr. Shackelford’s interests are wide-ranging, and include the investigation and study of the medical uses of cannabis as well as applying principles of behavioral medicine to the treatment of stress-related illnesses, obesity, insomnia and tobacco dependence.
He has advised legislators in Colorado and Connecticut on the medical uses of cannabis during deliberations on bills establishing and regulating medical use of cannabis, has testified a number of times before state senate and house committees in Colorado and Connecticut on the medical uses of marijuana and serves on the Colorado Department of Revenue Medical Marijuana Advisory Work Group and a similar group advising the City and County of Denver. Dr. Shackelford is principle physician of Amarimed of Colorado, a medical practice devoted to the study and evaluation of cannabis as a medical treatment option.
Dr. Moe Afaneh, Pharm. D.
Dr. Afaneh holds a Doctor of Pharmacy degree from Nova Southeastern University College of Pharmacy; he was accepted into the dual admission into the pharmacy program; entering college with 72 credits, and completed his doctorate in 6 years graduating at the top of his class, after which he received his MBA at Nova Southeastern University. Driven by a thirst for knowledge & determination to become a leader in the industry, to forge his mark in the medical community; he sought out to constantly gain more certifications & accreditation's; he became certified as an orthotic fitter, certified in providing vaccines, including Fluzone (the intra-nasal influenza vaccine), NIPCO certified in Osteoporosis, NIPCO certified in Long-Term Care & Hospice, NIPCO certified is Dyslipidemia and NPEC certified in chronic pain. His steps are similar to most great leaders seen in the early days of the pharmaceutical industry, those who are constantly innovating, adapting, and continuously working quality improvement.
Dr. William L. Courtney
Dr. William Courtney, in addition to holding a B.S. in Microbiology and M.D. degree, has a Post Doctorate in Forensic Examination and Forensic Medicine. He is a member of the International Cannabinoid Research Society, the International Association of Cannabis as Medicine, and the Society of Clinical Cannabis. Dr. Courtney teaches Continuing Medical Education (CME) courses in clinical cannabis, and a Survey Course on Endogenous Cannabinoid System, and hosted the Second International CB2 Conference in California.
Dr J. Thomas August
Dr. August’s distinguished career in clinical research directed at the molecular biology and protein structure of RNA viruses, and clinical exploration of human immunology has positioned him as a leading authority on human immune response mechanisms.
Dr. August currently holds the positions of a University Distinguished Service Professor of Pharmacology and Molecular Sciences, and Oncology at The Johns Hopkins University School of Medicine, Professor of Medicine, National University of Singapore; and Professor, Perdana University Graduate School of Medicine, Malaysia.
Dr. August has been involved with the development of a new generation of HIV vaccines and the protein antigenic structure of leading viral pathogens, including HIV-1, influenza, and other pathogens including dengue and West Nile viruses. His numerous publications are reflective of scientific commercial enterprises in cancer and HIV.
Dr. Ritchard L. Fishman
Dr. Fishman established his practice in 1961, and since then has been seeing patients of all ages for Diabetes, Hypertension, Weight Loss, Arthritis, Pain Management and many other medical problems. Dr. Fishman is widely recognized as a leader in the research in these fields. Since 1998, Dr. Fishman has been involved in clinical trials for medications, treatments, devices and vaccines for major pharmaceutical companies seeking FDA approval. Dr. Fishman is also a Chairman of the New Life Diabetes Center’s Medical Review Board and is responsible for reviewing all medical operations supervised by this Center. Dr. Fishman graduated Ohio State University in 1953 where he earned a Bachelor of Science degree with a Major in Biology. He also received his Medical Doctor degree from Ohio State University in 1957. Dr. Fishman has professional affiliations with the Downey Community Hospital, Whittier Presbyterian Hospital, and Whittier Hospital. Also, he has been a guest lecturer with the Western University School of Osteopathic Medicine and Senior Medical advisor for New Life Diabetic Centers in California and Nevada.
Dr. Mitch Earleywine
Dr. Earleywine is an Associate Professor of Psychology at the State University of New York (SUNY) at Albany. He has received numerous awards for his excellence in teaching and research. Dr. Earleywine has extensive experience in the areas of drug and alcohol abuse, and has published 89 peer reviewed scientific articles, many of which examine marijuana use. Additionally, Dr. Earleywine has authored 5 books including "The Parents Guide to Marijuana." He has professional affiliations with the Association for the Advancement of Behavior Therapy, the Research Society on Alcoholism Member; Dr. Earleywine is on the Advisory Board of the National Organization for the Reform of Marijuana Law (NORML) and is on the Executive Board of the Marijuana Policy Project (MPP).
Dr. Ben Johnson
Dr. Ben Johnson is a complementary and alternative medicine physician. After earning a degree in Osteopathy from the University of Health Sciences in Kansas City, he has since earned an M.D. degree and an N.M.D as well. He resigned as a founder and director of the Immune Recovery Clinic in Atlanta, Georgia after working there for several years to devote full time to The Healing Codes (A stress healing program that he uses to cure himself of Lou Gehbrig’s disease). In addition, Dr. Johnson served in the armed forces during Vietnam and was a flight surgeon in the army reserve for many years. He was a Senior Aviation Medical Examiner for the FAA for 12 years.
Currently, Dr. Johnson is owner of Dr. Ben Johnson Services, LLC, a business that promotes products for natural health care. He consults regularly with patients and health care professionals across the world, and his expertise is centered in the field of complimentary oncology.
Policy Advisory Board
Corporate - Policy Advisory Board
Robert J. Corry, Jr., Esq
Robert J. Corry, Jr. is a Denver-based civil rights and criminal defense attorney, specializing in medical marijuana, who has successfully litigated several high profile cases around the country. He is admitted to the bars of Colorado, California, and Washington, D.C., federal courts in these jurisdictions, as well as the U.S. Supreme Court. Mr. Corry earned his law degree from Stanford University.
Warren Edson, Esq
Warren Edson is an experienced criminal defense lawyer in Colorado having taken part in over 1,000 trials. He is also one of the organizers of Colorado's Medical Marijuana Law, Amendment 20, and is a Lifetime Member, NORML Legal Committee, and is a member, Colorado Criminal Defense Bar, and the National Association of Criminal Defense Lawyers, and is a Board Member, Colorado NORML.
Sean T. McAllister, Esq
Sean T. McAllister is public interest attorney with offices in Denver and Summit County. Sean has been involved with drug policy reform efforts for over a decade. Sean serves as the Chair of the Board of Directors of Sensible Colorado. Sean is a lifetime member of the NORML Legal Committee. He is a member and Board member of the Colorado Criminal Defense Bar. He helped start the Colorado Bar Association Criminal Sentencing Project in 2005 to focus on criminal justice and drug policy reform. Recently, Sean was appointed to the Governor's Drug Policy Task Force, which is working on reducing drug-sentencing laws to save the state money while maintaining public safety. Along with Brian Vicente, Sean recently founded the Canna-Business Institute designed to educate dispensary owners and caregivers on how to legally operate medical marijuana businesses in Colorado.
Robert Raich, Esq
Robert A. Raich practices law in Oakland, California, and is a graduate of Harvard University and the University of Texas School of Law. He is one of the most respected attorneys in the area of medical marijuana. He is General Counsel of the Oakland Cannabis Buyers' Cooperative, and was one of the attorneys in the U.S. Supreme Court case, United States v. Oakland Cannabis Buyers' Coop. and another federal medical cannabis case. He is a member of the California Attorney General's Medical Marijuana Task Force (Chairman, Caregiver Issues Subcommittee).
Ive seen many companies have to change business plans many a times. Most start ups fail. They discovered better products and markets, so lets do this thing!
Big bounce play in effect IMO GO
$CBIS :)
Never do toooo much toooo early or you will be forced into a good day
Soon enough all shall see the empire that is to be...
Nice grab! Best I got was 5 :). Bottom and turn around?
Gonna be looking for two's for sure :)
Good news. go nadvf oops i mean RCLRF!
CBIS wants to breathe over that .053! Hold Strong support! :)
Interest over Legalized Weed Has Taken Lift off Folk! :)
Source:http://www.google.com/trends/explore#q=legalize%20weed
GL $CBIS
i would imagine that the short interest would have to be much higher to have/had any effect on the stock?
All we need is a diversity of good results and I'm sure we can see a significant growth in sales. Do you know if we would be able to handle a high demand?
So this means the 91,437 short interest rate must be covered in the next two days?
Help me out here, could you explain to me exactly what that data means?>
Anyone else see the spotted pigeon? Ah a dimeond it holds!
A update with estimated revues for 2013 would be an awesome thing to hear from the company. Here is a wonderful time for Chicago!
BOUNCE play inc after lunch
Definitely better questions indeed. NPU's are what ~600K a piece?